Mechanism‐based pharmacodynamic modeling
暂无分享,去创建一个
[1] G. Segre,et al. Kinetics of interaction between drugs and biological systems. , 1968, Il Farmaco; edizione scientifica.
[2] G. Levy,et al. Kinetics of the anticoagulant effect of bishydroxycoumarin in man , 1970, Clinical pharmacology and therapeutics.
[3] G. Levy,et al. Kinetics of pharmacologic effects in man: The anticoagulant action of warfarin , 1969, Clinical pharmacology and therapeutics.
[4] L B Sheiner,et al. Simultaneous modeling of pharmacokinetics and pharmacodynamics: application to d-tubocurarine. , 1980, Clinical pharmacology and therapeutics.
[5] G. Levy,et al. Pharmacokinetic analysis of the effect of barbiturate on the anticoagulant action of warfarin in man , 1970, Clinical pharmacology and therapeutics.
[6] L. B. Wingard,et al. Comparative pharmacokinetics of coumarin anticoagulants. X. Relationship between distribution, elimination, and anticoagulant action of warfarin. , 1974, Journal of pharmaceutical sciences.
[7] H. Thijssen,et al. The relationship between the vitamin K cycle inhibition and the plasma anticoagulant response at steady-state S-warfarin conditions in the rat. , 1992, Journal of Pharmacology and Experimental Therapeutics.
[8] W J Jusko,et al. Physiologic indirect response models characterize diverse types of pharmacodynamic effects , 1994, Clinical pharmacology and therapeutics.
[9] Malcolm Rowland,et al. Population pharmacokinetics and pharmacodynamics of warfarin in healthy young adults , 1993 .